نمایش پرونده ساده آیتم

dc.contributor.authorMahmoudi, J
dc.contributor.authorFarhoudi, M
dc.contributor.authorReyhani-Rad, S
dc.contributor.authorSadigh-Eteghad, S
dc.date.accessioned2018-08-26T08:51:22Z
dc.date.available2018-08-26T08:51:22Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53361
dc.description.abstractDuring long-term treatment with Levodopa, majority of patients with Parkinson's disease experience some abnormal motor problems including of Levodopa induced dyskinesia (LID) and wearing off. Incredible evidences suggest that serotonergic neurons compensate some functions of lost dopaminergic neurons in Parkinson's disease especially in advanced disease stages. Therefore, it has been postulated that serotonergic neurons are the major source for development of these unwanted effects. 5HT1A receptors are located on the serotonergic neurons and are involved in regulation of normal motor functions. With respect to the role of serotonergic projection in Parkinson's disease and importance of 5HT1A receptors in motor activity it seems that inactivation of these neurons by stimulation of 5HT1A receptors could provide benefits in treatment of Levodopa induced motor impairments. é 2013 by Tabriz University of Medical Sciences.
dc.language.isoEnglish
dc.relation.ispartofAdvanced Pharmaceutical Bulletin
dc.subjectaromatic levo amino acid decarboxylase
dc.subjectlevodopa
dc.subjectserotonin 1A agonist
dc.subjectserotonin 1A receptor
dc.subjectvesicular monoamine transporter 2
dc.subjectarticle
dc.subjectchorea
dc.subjectchronic drug administration
dc.subjectdopamine release
dc.subjectdopaminergic system
dc.subjectdrug effect
dc.subjectdrug mechanism
dc.subjectdrug targeting
dc.subjectdyskinesia
dc.subjectdystonia
dc.subjecthuman
dc.subjectmotor dysfunction
dc.subjectneuropathology
dc.subjectneurotransmitter release
dc.subjectnonhuman
dc.subjectParkinson disease
dc.subjectpharmacological stimulation
dc.subjectprotein expression
dc.subjectreceptor upregulation
dc.subjectserotonin release
dc.subjectserotoninergic nerve cell
dc.subjectserotoninergic system
dc.subjectsynapse vesicle
dc.titleDampening of serotonergic system through 5HT1A receptors is a promising target for treatment of levodopa induced motor problems
dc.typeArticle
dc.citation.volume3
dc.citation.issue2
dc.citation.spage439
dc.citation.epage441
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.5681/apb.2013.071


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم